NO990836L - Antitrombotiske azacykloalkylalkanoylpeptider og pseudopeptider - Google Patents

Antitrombotiske azacykloalkylalkanoylpeptider og pseudopeptider

Info

Publication number
NO990836L
NO990836L NO990836A NO990836A NO990836L NO 990836 L NO990836 L NO 990836L NO 990836 A NO990836 A NO 990836A NO 990836 A NO990836 A NO 990836A NO 990836 L NO990836 L NO 990836L
Authority
NO
Norway
Prior art keywords
pseudopeptides
antithrombotic
azacycloalkylalkanoyl peptides
peptides
intermediates
Prior art date
Application number
NO990836A
Other languages
English (en)
Norwegian (no)
Other versions
NO990836D0 (no
Inventor
Scott I Klein
Bruce F Molino
Mark Czekaj
Charles J Gardner
Original Assignee
Rhone Poulenc Rorer Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Pharma filed Critical Rhone Poulenc Rorer Pharma
Publication of NO990836D0 publication Critical patent/NO990836D0/no
Publication of NO990836L publication Critical patent/NO990836L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06104—Dipeptides with the first amino acid being acidic
    • C07K5/06113—Asp- or Asn-amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO990836A 1996-08-21 1999-02-22 Antitrombotiske azacykloalkylalkanoylpeptider og pseudopeptider NO990836L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/700,950 US5780590A (en) 1993-10-15 1996-08-21 Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides
PCT/US1997/014578 WO1998017678A1 (en) 1996-08-21 1997-08-15 Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides

Publications (2)

Publication Number Publication Date
NO990836D0 NO990836D0 (no) 1999-02-22
NO990836L true NO990836L (no) 1999-04-20

Family

ID=24815484

Family Applications (1)

Application Number Title Priority Date Filing Date
NO990836A NO990836L (no) 1996-08-21 1999-02-22 Antitrombotiske azacykloalkylalkanoylpeptider og pseudopeptider

Country Status (21)

Country Link
US (1) US5780590A (pt)
EP (1) EP0929572A4 (pt)
JP (1) JP2001501965A (pt)
KR (1) KR20000035797A (pt)
CN (1) CN1231671A (pt)
AP (1) AP904A (pt)
AU (1) AU722112B2 (pt)
BG (1) BG103197A (pt)
BR (1) BR9711205A (pt)
CA (1) CA2263732A1 (pt)
EA (1) EA001391B1 (pt)
HU (1) HUP9903961A3 (pt)
IL (1) IL128556A0 (pt)
NO (1) NO990836L (pt)
NZ (1) NZ334059A (pt)
OA (1) OA10975A (pt)
PL (1) PL331713A1 (pt)
SK (1) SK14699A3 (pt)
UA (1) UA48252C2 (pt)
WO (1) WO1998017678A1 (pt)
ZA (1) ZA977511B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6274705B1 (en) 1996-05-02 2001-08-14 Aventis Pharmaceuticals Products Inc. Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides
CN1231659A (zh) * 1996-08-21 1999-10-13 罗纳·布朗克罗尔药制品有限公司 N[n－n－(4－哌啶－4－基)丁酰基)－n－乙基甘氨酰基]化合物的不吸湿的稳定结晶形式
WO1999019294A1 (en) * 1997-05-14 1999-04-22 Aventis Pharmaceuticals Products Inc. Legal/Patents Process for the preparation of azacycloalkylalkanoyl pseudotetrapeptides
EP1030831A4 (en) * 1997-10-10 2003-01-02 Aventis Pharm Prod Inc PREPARATION OF AZACYCLOALKYLALCANOYL PSEUDOTETRAPEPTIDES
WO2000040601A1 (en) * 1998-12-30 2000-07-13 Aventis Pharmaceuticals Products Inc. Process for preparing a stable non-hygroscopic crystalline n-[n-[n- piperdin- 4-yl)butanoyl)- n.ethylglycyl]- (l)-aspartyl] -ss-cyclohexylalanine amide
US7200838B2 (en) * 2000-12-20 2007-04-03 National Instruments Corporation System and method for automatically generating a graphical program in response to a state diagram
US7544681B2 (en) 2001-09-27 2009-06-09 Ramot At Tel Aviv University Ltd. Conjugated psychotropic drugs and uses thereof
ES2400772T3 (es) * 2005-06-07 2013-04-12 Ramot At Tel Aviv University Ltd. Sales novedosas de fármacos psicotrópicos conjugados y procedimientos para la preparación de las mismas
ES2393933T3 (es) 2006-07-17 2013-01-02 Ramot, At Tel Aviv University Ltd. Conjugados que comprenden un fármaco psicotrópico o un agonista GABA y un ácido orgánico y su uso para el tratamiento del dolor y otros transtornos del SNC
US8207369B2 (en) 2008-02-11 2012-06-26 Ramot At Tel-Aviv University Ltd. Conjugates for treating neurodegenerative diseases and disorders
EP2509603A1 (en) 2009-12-09 2012-10-17 Biolinerx Ltd. Methods of improving cognitive functions
US8377929B2 (en) 2010-02-24 2013-02-19 Ramot At Tel-Aviv University Ltd. Crystalline forms of the tri-mesylate salt of perphenazine-GABA and process of producing the same
WO2012038963A1 (en) 2010-09-22 2012-03-29 Ramot At Tel-Aviv University Ltd. An acid addition salt of a nortriptyline-gaba conjugate and a process of preparing same

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3821188A (en) * 1972-06-14 1974-06-28 American Home Prod Proline and pyroglutamic acid containing tripeptides
GB8600263D0 (en) * 1985-01-22 1986-02-12 Ici America Inc Peptide derivatives
US4683291A (en) * 1985-10-28 1987-07-28 Scripps Clinic And Research Foundation Platelet binding inhibitors
FR2608160B1 (fr) * 1986-12-15 1989-03-31 Inst Nat Sante Rech Med Nouveaux derives peptidiques et leur application notamment en therapeutique
US4857508A (en) * 1987-12-03 1989-08-15 Monsanto Company Novel platelet-aggregation inhibitor peptide derivatives
US4879313A (en) * 1988-07-20 1989-11-07 Mosanto Company Novel platelet-aggregation inhibitors
US5037808A (en) * 1988-07-20 1991-08-06 Monsanto Co. Indolyl platelet-aggregation inhibitors
US4992463A (en) * 1988-07-20 1991-02-12 Monsanto Company Thienyl peptide mimetic compounds which are useful in inhibiting platelet aggregation
US5023233A (en) * 1989-07-28 1991-06-11 Merck & Co., Inc. Fibrinogen receptor antagonists
EP0494248A4 (en) * 1989-09-29 1992-08-26 Rhone-Poulenc Rorer International (Holdings) Inc. Anti-thrombotic peptides and pseudopeptides
US4952562A (en) * 1989-09-29 1990-08-28 Rorer Pharmaceutical Corporation Anti-thrombotic peptides and pseudopeptides
US5051405A (en) * 1989-10-10 1991-09-24 Rhone-Poulenc Rorer Pharmaceuticals Inc. Anti-thrombotic peptides and pseudopeptides
US5053392A (en) * 1989-12-01 1991-10-01 Rhone-Poulenc Rorer Pharmaceuticals Inc. Novel arginine, glycine, aspartic acid derivatives as platelet-aggregation inhibitors
US5086069A (en) * 1990-02-05 1992-02-04 Rorer Pharmaceutical Corporation Anti-thrombotic peptide and pseudopeptide derivatives
CA2037153A1 (en) * 1990-03-09 1991-09-10 Leo Alig Acetic acid derivatives
GB9007751D0 (en) * 1990-04-05 1990-06-06 Ciba Geigy Ag Novel platelet-aggregation inhibitors
US5064814A (en) * 1990-04-05 1991-11-12 Rhone-Poulenc Rorer Pharmaceuticals Inc. Anti-thrombotic peptide and pseudopeptide derivatives
NZ239876A (en) * 1990-09-27 1993-12-23 Merck & Co Inc Glycyl-b-alanine derivatives and pharmaceutical compositions thereof.
IL99539A0 (en) * 1990-09-27 1992-08-18 Merck & Co Inc Fibrinogen receptor antagonists and pharmaceutical compositions containing them
MX9201416A (es) * 1991-03-28 1992-10-01 Rhone Poulenc Rorer Int Peptidos y pseudopeptidos antitromboticos.
JPH08503920A (ja) * 1991-04-11 1996-04-30 ローヌ−プーラン ローラー インターナショナル（ホウルディングス） インコーポレイテッド 抗血栓ペプチドおよび偽ペプチド誘導体
DK0513675T3 (da) * 1991-05-13 1996-09-30 Fujisawa Pharmaceutical Co Hidtil ukendt peptidforbindelse samt fremgangsmåde til fremstilling deraf
SK47796A3 (en) * 1993-10-15 1997-03-05 Rhone Poulenc Rorer Pharma Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides

Also Published As

Publication number Publication date
ZA977511B (en) 1998-03-03
HUP9903961A2 (hu) 2000-04-28
PL331713A1 (en) 1999-08-02
EA001391B1 (ru) 2001-02-26
EA199900216A1 (ru) 1999-08-26
HUP9903961A3 (en) 2000-12-28
BR9711205A (pt) 1999-08-17
US5780590A (en) 1998-07-14
KR20000035797A (ko) 2000-06-26
AP9901452A0 (en) 1999-03-31
JP2001501965A (ja) 2001-02-13
NO990836D0 (no) 1999-02-22
AP904A (en) 2000-11-24
CA2263732A1 (en) 1998-04-30
SK14699A3 (en) 2000-11-07
OA10975A (en) 2001-11-01
IL128556A0 (en) 2000-01-31
AU722112B2 (en) 2000-07-20
EP0929572A4 (en) 2001-09-12
BG103197A (bg) 2000-05-31
UA48252C2 (uk) 2002-08-15
CN1231671A (zh) 1999-10-13
AU4074997A (en) 1998-05-15
WO1998017678A1 (en) 1998-04-30
NZ334059A (en) 2000-01-28
EP0929572A1 (en) 1999-07-21

Similar Documents

Publication Publication Date Title
AU662345B2 (en) Pyrrolidine and thiazolidine derivatives, preparation thereof and drugs containing same
FI91072C (fi) Menetelmä terapeuttisesti aktiivisten heterosyklisten peptidien valmistamiseksi ja niiden valmistuksessa käyttökelpoisia välituotteita
NO990721L (no) Stabil ikke-hygroskopisk krystallinsk form av N-[N-N-(4-(piperidin-4-yl)butanoyl)-N-etylglysyl]forbindelser
CA2042001A1 (en) Peptide amides, processes for the preparation thereof and agents containing these as fibrin/thrombin clotting inhibitors
NO303687B1 (no) Analogifremgangsmåte for fremstilling av den terapeutisk aktive forbindelse (S)(+)-2-etoksy-4-[N-[1-(2-piperidino-fenyl)-3-metyl-1-butyl]aminokarbonylmetyl]-benzosyre
CA2230082A1 (en) Amide compounds and use thereof
MY132473A (en) Crystalline hydrochloride of (r)-(-)-2-<n-[4-(1,1- dioxido-3-oxo-2,3-dihydro-benzisothiazol-2-yl)-butyl]-aminomethyl>-chroman
RO117913B1 (ro) Derivaţi de n-[(amino-(imino)metil)fenil]propil amide substituite, compoziţie farmaceutică care îi conţine şi metodă de tratament
BG103197A (bg) Антитромботични азациклоалкилалканоил пептиди и псевдопептиди
ZA952975B (en) New biaromatic acetylene compounds containing an adamantyl group pharmaceutical and cosmetic compositions containing them and uses
FI892688A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten oligopeptidien valmistamiseksi, joissa on proliinille analogisia syklisiä aminohappoja
BG101220A (bg) N-заместени 3-азабицикло(3.2.0) хептанови производни, метод за получаване и използването им
FI903571A0 (fi) Menetelmä farmaseuttisesti aktiivisten peptidien valmistamiseksi
PT736029E (pt) Sulfamatos de pseudofructopiranose anticonvulsivos
GR862021B (en) Process for obtaining aminoalcohols peptidic derivatives containing a tetrasubstituted carbon atom as inhibitors of renine and acid proteases
AU1198897A (en) 1-benzenesulfonyl pyrrolidine derivatives as bradykinin receptor antagonists
NO891484L (no) Fremgangsmaate for fremstilling av cyklometylen-1,2-bikarboksylsyreamider med terapeutisk aktivitet og farmasoeytiskesammensetninger derav.
NO173991C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,2,5-ditiazocin-derivater
TW221429B (pt)
IL70676A (en) Derivatives of n-(hydroxy)dipeptides,process for their preparation and pharmaceutical compositions containing them
US4482725A (en) S-Acylation products of mercaptoacyl amino acids and carboxyl group containing diuretics
DE69810651D1 (de) Azetidinonderivate zur behandlung von hcmv entzündungen
NO934741L (no) Fremgangsmåte for minimalisering og kontroll av ischemiske og reperfusjonsskade
EA200101109A1 (ru) Производные 1-трифторметил-4-гидрокси-7-пиперидинил-аминометилхромана
ATE80380T1 (de) Diastereoselektives verfahren zur herstellung von zwischenprodukten verwendbar zur peptidderivatensynthese.